Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Redeeming credit card points can be tricky. Discover what to avoid to ensure you make the most out of your rewards and benefits.
19,422 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Bitcoin briefly peaked above $69k this week before pulling back toward $65k as equity markets turned lower and gold c...
March is delivering a notable rally as investors weigh AI momentum, earnings signals, and geopolitical headlines. Thi...
Cruise investors wrestle with Carnival earnings anxiety: good, the push-pull between sunny passenger demand and risin...
Markets opened with caution, nudging major indexes lower as investors weighed earnings and inflation data. This guide...
A midweek rally lifted U.S. stocks as investors weighed geopolitical headlines and a high-profile IPO. The Nasdaq led...
Tech stocks are leading the charge, lifting major indices to new highs. This guide breaks down the drivers, the bigge...
Nvidia has stumbled from its record highs in 2026, but a dip can offer opportunity—if you know how to evaluate the od...
Ethereum faces near-term headwinds, but a rebound may follow a deeper pullback. This analysis translates Standard Cha...
If you're 30 and chasing big growth, this guide shows the best funds for aggressive growth at 30, plus a step-by-step...
A public reflection on relationships can double as a financial guide. This article pulls lessons from a famous split ...
Midweek headlines can turn crypto markets on a dime. This piece explains the drivers behind bitcoin sinking wednesday...